Biccirè Flavio Giuseppe, Gatto Laura, Prati Francesco
Cardiovascular Sciences Department, San Giovanni Addolorata Hospital, Rome.
Centro per la Lotta contro l'Infarto, CLI Foundation, Rome.
Eur Heart J Suppl. 2024 Apr 17;26(Suppl 1):i11-i14. doi: 10.1093/eurheartjsupp/suae004. eCollection 2024 Apr.
Despite notable advances in devices and techniques, percutaneous coronary intervention (PCI) is still affected by a substantial number of complications and failure rates. Over the years, the use of intracoronary imaging (ICI) has dramatically improved the understanding of mechanical and technical factors related to successful and failed PCI, becoming a mainstay in complex trans-catheter interventions. However, ICI modalities are invasive, time-consuming, and costly, and a net clinical benefit needs to be shown in order to recommend their routine use in clinical practice. In the past, the lack of evidence from randomized trials has been reflected in the scepticism shown by international guidelines. The recent publication of large randomized clinical trials conducted worldwide has provided new evidence regarding the clinical usefulness of ICI guidance in PCI. The consistent reduction of adverse events achieved in these trials, also demonstrated in an updated meta-analysis, suggested that the use of ICI in PCI is compelling to achieve optimal technical results and better outcomes, especially in complex high-risk interventions. Also considering the burden of information provided by ICI on coronary artery disease, looking from the inside seems today an opportunity that modern cardiology cannot ignore anymore.
尽管在设备和技术方面取得了显著进展,但经皮冠状动脉介入治疗(PCI)仍然受到大量并发症和失败率的影响。多年来,冠状动脉内成像(ICI)的应用极大地增进了人们对与成功和失败的PCI相关的机械和技术因素的理解,成为复杂经导管介入治疗的支柱。然而,ICI模式具有侵入性、耗时且成本高昂,需要证明其具有净临床益处才能推荐在临床实践中常规使用。过去,随机试验缺乏证据反映在国际指南所表现出的怀疑态度上。最近在全球范围内开展的大型随机临床试验的发表,为ICI指导在PCI中的临床实用性提供了新证据。这些试验中不良事件的持续减少,在一项更新的荟萃分析中也得到了证实,表明在PCI中使用ICI对于获得最佳技术结果和更好的预后是令人信服的,尤其是在复杂的高风险介入治疗中。同时考虑到ICI提供的关于冠状动脉疾病的信息量,从内部观察如今似乎是现代心脏病学不能再忽视的一个机会。